Recent

% | $
Quotes you view appear here for quick access.

Pharmacyclics Inc. Message Board

  • riffissimo riffissimo Apr 10, 2013 8:41 AM Flag

    Key Events

    PCYC is suffering from too much news. These are the key events I have on my calendar

    Q2-2013
    - Q1 quarterly earnings conference call with filing updates
    - ASCO. Lots of updates, maybe something new.

    Q3-2013
    - Preliminary Spark R/R MCL response data (internal)

    Q4-2013
    - R/R MCL filing
    - ASH - Preliminary Spark results

    Q2-2014
    - R/R MCL approval and launch with priority review

    Interspersed is potential upside news on myeloma, maybe pancreatic, autoimmune compound, firm European filing plans, filing plans for Japan and Asia, regulatory and approval milestones, trial enrollment news, next two breakthrough designation approvals, then first line approvals.

    http://finance.yahoo.com/news/pharmacyclics-first-announce-breakthrough-therapy-001300706.html

    "The company expects to finalize the MCL filing prior to year end and will provide guidance on the WM filing after further discussions with the FDA. "

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PCYC
254.75+0.24(+0.09%)May 4 4:00 PMEDT